Walters-Shumka, Jonathan P.
Sorrentino, Stefano
Nygaard, Haakon B.
Willerth, Stephanie M. http://orcid.org/0000-0002-1665-7723
Funding for this research was provided by:
Canada Research Chairs (Tier II Chair in Biomedical Engineering)
Materials Research Science and Engineering Center, Harvard University (natural sciences and engineering research council)
Institute of Neurosciences, Mental Health and Addiction (Project Grant)
Article History
Accepted: 10 May 2023
First Online: 14 June 2023
Conflict of interest
: S. Willerth is the CEO of Axolotl Biosciences, a startup focused on selling novel bioinks for bioprinting human tissue models. The remaining authors declare that there is no conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable.